Literature DB >> 6386855

Detection of Semliki Forest virus in cell culture by use of an enzyme immunoassay with peroxidase-labeled monoclonal antibodies specific for glycoproteins E1 and E2.

F H van Tiel, W A Boere, J Vinjé, T Harmsen, B J Benaissa-Trouw, C A Kraaijeveld, H Snippe.   

Abstract

Four noncompeting monoclonal antibodies (MA) directed against either the E1 (UM 8.64 and 8.139) or E2 (UM 8.55 and 8.73) glycoprotein of Semliki Forest virus were purified and labeled with horseradish peroxidase. Each enzyme-labeled MA was tested alone and in combination with others for its sensitivity to detect virus-infected cells. Semliki Forest virus-infected L cells seeded as monolayers in 96-well plates were screened for the virus after incubation with enzyme-labeled MA and a substrate. In this system single enzyme-labeled MA even at high dilution (10(3.0) to 10(4.5] were able to detect virus-infected cells. The sensitivity of the test could be enhanced by combining two noncompeting MA (10(4.5) to 10(5.0]. Combinations of three and four MA were less effective, due to high absorbance values for noninfected cells. The threshold of virus defection was between 10(5) and 10(6) PFU/ml. This test is sensitive and specific and therefore may be useful for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386855      PMCID: PMC271335          DOI: 10.1128/jcm.20.3.387-390.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Antibody-dependent, complement-mediated homologous and cross-cytolysis of togavirus-infected cells.

Authors:  B King; C J Wust; A Brown
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

2.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  The rapid titration of Semliki forest virus in cell monolayers by immunofluorescence.

Authors:  G B Carter
Journal:  J Gen Virol       Date:  1969-01       Impact factor: 3.891

4.  Monoclonal antibodies for diagnosis of infectious diseases in humans.

Authors:  R C Nowinski; M R Tam; L C Goldstein; L Stong; C C Kuo; L Corey; W E Stamm; H H Handsfield; J S Knapp; K K Holmes
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

Review 5.  Monoclonal antibodies: a powerful new tool in biology and medicine.

Authors:  D E Yelton; M D Scharff
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Delayed-type hypersensitivity against Semliki Forest virus in mice.

Authors:  C A Kraaijeveld; M Harmsen; B Khader Boutahar-Trouw
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Replication of Semliki Forest virus: an electron microscopic study.

Authors:  N H Acheson; I Tamm
Journal:  Virology       Date:  1967-05       Impact factor: 3.616

8.  Investigations into yellow fever virus and other arboviruses in the northern regions of Kenya.

Authors:  B E Henderson; D Metselaar; G B Kirya; G L Timms
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia.

Authors:  L C Goldstein; J McDougall; R Hackman; J D Meyers; E D Thomas; R C Nowinski
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates.

Authors:  N J Schmidt; M Ota; D Gallo; V L Fox
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

View more
  7 in total

1.  Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.

Authors:  W A Boere; M Harmsen; C A Kraaijeveld; H Snippe
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies.

Authors:  F H van Tiel; W A Boere; T Harmsen; C A Kraaijeveld; H Snippe
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

3.  Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.

Authors:  F H van Tiel; T Harmsen; M Wagenaar; W A Boere; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

4.  Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.

Authors:  W A Boere; B J Benaissa-Trouw; T Harmsen; T Erich; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.

Authors:  W A Boere; B J Benaissa-Trouw; T Harmsen; T Erich; C A Kraaijeveld; H Snippe
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

6.  Neutralization enzyme immunoassay for influenza virus.

Authors:  C A Benne; M Harmsen; J C De Jong; C A Kraaijeveld
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon.

Authors:  F Vlaspolder; T Harmsen; D van Veenendaal; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.